These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25880145)

  • 1. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury.
    Kumphune S; Surinkaew S; Chattipakorn SC; Chattipakorn N
    Pharm Biol; 2015; 53(12):1831-41. PubMed ID: 25880145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart.
    Surinkaew S; Kumphune S; Chattipakorn S; Chattipakorn N
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):133-41. PubMed ID: 23107875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing the anti-ischemia-reperfusion injury effects of ginsenoside Rb1 mediated through the inhibition of p38α MAPK.
    Li G; Qian W; Zhao C
    Can J Physiol Pharmacol; 2016 Jan; 94(1):97-103. PubMed ID: 26550918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin Enhances Sarcoplasmic Reticulum Ca2+-ATPase Activity through p38 MAPK Signaling thus Improving Rat Cardiac Function after Ischemia/Reperfusion.
    Zhu S; Xu T; Luo Y; Zhang Y; Xuan H; Ma Y; Pan D; Li D; Zhu H
    Cell Physiol Biochem; 2017; 41(3):999-1010. PubMed ID: 28222421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes.
    Engelbrecht AM; Niesler C; Page C; Lochner A
    Basic Res Cardiol; 2004 Sep; 99(5):338-50. PubMed ID: 15309413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection.
    Gao XF; Zhou Y; Wang DY; Lew KS; Richards AM; Wang P
    Mol Cell Biochem; 2015 Jan; 398(1-2):135-46. PubMed ID: 25245818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p38 mitogen-activated protein kinase may decrease intestinal epithelial cell apoptosis and improve intestinal epithelial barrier function after ischemia- reperfusion injury.
    Zheng SY; Fu XB; Xu JG; Zhao JY; Sun TZ; Chen W
    World J Gastroenterol; 2005 Feb; 11(5):656-60. PubMed ID: 15655816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo.
    Wang J; Yang H; Hu X; Fu W; Xie J; Zhou X; Xu W; Jiang H
    J Surg Res; 2013 Aug; 183(2):509-16. PubMed ID: 23531454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferulic Acid Administered at Various Time Points Protects against Cerebral Infarction by Activating p38 MAPK/p90RSK/CREB/Bcl-2 Anti-Apoptotic Signaling in the Subacute Phase of Cerebral Ischemia-Reperfusion Injury in Rats.
    Cheng CY; Tang NY; Kao ST; Hsieh CL
    PLoS One; 2016; 11(5):e0155748. PubMed ID: 27187745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
    Barancik M; Htun P; Strohm C; Kilian S; Schaper W
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):474-83. PubMed ID: 10710135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning.
    Yoshimura Y; Kristo G; Keith BJ; Jahania SA; Mentzer RM; Lasley RD
    Cardiovasc Drugs Ther; 2004 Nov; 18(6):433-40. PubMed ID: 15770430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
    Ma XL; Kumar S; Gao F; Louden CS; Lopez BL; Christopher TA; Wang C; Lee JC; Feuerstein GZ; Yue TL
    Circulation; 1999 Apr; 99(13):1685-91. PubMed ID: 10190877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization.
    Jaswal JS; Gandhi M; Finegan BA; Dyck JR; Clanachan AS
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1107-14. PubMed ID: 17496214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury.
    Yu D; Li M; Tian Y; Liu J; Shang J
    Life Sci; 2015 Feb; 122():15-25. PubMed ID: 25476833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic preconditioning or p38 MAP kinase inhibition attenuates myocardial TNF alpha production and mitochondria damage in brief myocardial ischemia.
    Kimura H; Shintani-Ishida K; Nakajima M; Liu S; Matsumoto K; Yoshida K
    Life Sci; 2006 Mar; 78(17):1901-10. PubMed ID: 16497338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
    Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
    Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
    Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
    Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
    Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.